Author： Yamabhai Inthira Smith Richard D.
Publisher： Inderscience Publishers
ISSN： 1478-9647
Source： International Journal of Intellectual Property Management, Vol.6, Iss.4, 2013-11, pp. : 272-284
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
This study aims to illustrate the processes to determine medicine patent status in developing countries by using oncology medicine in Thailand as a case study. From 88 active ingredients, 31 active ingredients were found to have been filed for patent protection in Thailand, while seven medicines were unable to be verified as being patented. Patent identification is very complex and time-consuming, which leads to the inability to identify patented medicine. As such, developing countries may therefore find that they pay more than required for some medicines simply due to this lack of information. Government authorities in developing countries should therefore strengthen their systems for gathering, validating and disseminating patent information for pharmaceuticals to ensure that disclosure is on par with the developed world.
Related content
Access to resources
Recommend
Transdermal Drug Delivery System: Patent Reviews
Recent Patents on Drug Delivery & Formulation, Vol. 3, Iss. 2, 2009-06 ,pp. :